Viracta Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viracta Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $216 | 382 | 0.57 |
| 2023-09-30 | $384 | 370 | 1.04 |
| 2023-06-30 | $484 | 343 | 1.41 |
| 2022-12-31 | $484 | 332 | 1.46 |
| 2022-09-30 | $2.1k | 326 | 6.45 |
| 2022-06-30 | $1.7k | 303 | 5.71 |
| 2022-03-31 | $310k | 65k | 4.76 |
| 2021-12-31 | $277k | 76k | 3.65 |
| 2021-09-30 | $83k | 10k | 7.93 |
| 2021-06-30 | $19k | 1.7k | 11.09 |
| 2021-03-31 | $74k | 7.9k | 9.27 |